Hemogenyx Pharmaceuticals advances HG-CT-1 trial and opens paediatric recruitment

FDA grants Augurex Life Sciences breakthrough designation for SPINEstat diagnostic test in axial spondyloarthritis

CStone announces Phase I CS2009 data at ESMO 2025

Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities

Bristol Myers Squibb to acquire Orbital Therapeutics for USD1.5bn to expand cell therapy portfolio

Celltrion launches AVTOZMA IV in the United States following FDA approval

OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University

Dr Eric Berg Joins Forces with Robert F. Kennedy Jr. to Advocate for Transparency in Vaccine Science and Public Health

Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem

EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi

Nanjing Leads Biolabs receives FDA approval of IND application for LBL-047

J & D Pharmaceuticals receives Orphan Drug Designation for JD-004

Hemogenyx reports positive safety and early efficacy data from third patient in CAR-T trial

Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium

Hemogenyx Pharmaceuticals partners with Made Scientific to advance CAR-T therapy